| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7384649 | ACORDA | Particulate compositions for pulmonary delivery |
Nov, 2022
(10 months ago) | |
| US9155699 | ACORDA | Pulmonary delivery for levodopa |
Mar, 2023
(6 months ago) | |
| US8404276 | ACORDA | Pulmonary delivery for levodopa |
Mar, 2023
(6 months ago) | |
| US8586093 | ACORDA | Pulmonary delivery for levodopa |
Mar, 2023
(6 months ago) | |
| US7182961 | ACORDA | Particulate compositions for pulmonary delivery |
Feb, 2024
(4 months from now) | |
| USRE43711 | ACORDA | Pulmonary delivery for levodopa |
Feb, 2029
(5 years from now) | |
| US8945612 | ACORDA | Capsules containing high doses of levodopa for pulmonary use |
Nov, 2032
(9 years from now) | |
| US8685442 | ACORDA | Capsules containing high doses of levodopa for pulmonary use |
Nov, 2032
(9 years from now) | |
| US9393210 | ACORDA | Capsules containing high doses of levodopa for pulmonary use |
Nov, 2032
(9 years from now) | |
| US8545878 | ACORDA | Capsules containing high doses of levodopa for pulmonary use |
Nov, 2032
(9 years from now) | |
Inbrija is owned by Acorda.
Inbrija contains Levodopa.
Inbrija has a total of 10 drug patents out of which 4 drug patents have expired.
Expired drug patents of Inbrija are:
- US7384649
- US9155699
- US8404276
- US8586093
Inbrija was authorised for market use on 21 December, 2018.
Inbrija is available in powder;inhalation dosage forms.
Inbrija can be used as intermittent treatment of off episodes in patients with parkinson's disease treated with carbidopa/levodopa by inhalation of levodopa powder particles.
The generics of Inbrija are possible to be released after 16 November, 2032.
Drugs and Companies using LEVODOPA ingredient
Market Authorisation Date: 21 December, 2018
Treatment: Intermittent treatment of off episodes in patients with parkinson's disease treated with carbidopa/levodopa by inhalation of levodopa powder particles
Dosage: POWDER;INHALATION
INBRIJA family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic